Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-13 Purchase |
2021-05-17 07:00 am |
Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director |
5,925,925 | $1.35 | $7,999,999 | 7,804,778 (Indirect) |
View |
| 2020-11-17 Purchase |
2020-11-19 4:39 pm |
Keros Therapeutics Inc. | KROS | Kariv Tomer Pontifax (Israel) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax Late Stage Fund L.P. Pontifax Late Stage GP Ltd. Director 10% Owner |
60,000 | $50 | $3,000,000 | 155,262 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-30 Option Award |
2024-06-03 4:15 pm |
N/A 2034-05-29 |
Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:45 pm |
N/A 2033-06-05 |
Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-01-30 Option Award |
2023-01-31 4:08 pm |
N/A 2033-01-30 |
Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director |
2,859 | $0 | 2,859 (Direct) |
View |
| 2022-11-29 Exercise |
2022-11-30 4:38 pm |
N/A 2023-10-07 |
Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner |
7,176 | $0 | 1,226,412 (Indirect) |
View |
| 2022-11-29 Exercise |
2022-11-30 4:38 pm |
N/A N/A |
Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner |
7,176 | $0.0001 | 1,226,412 (Indirect) |
View |
| 2022-06-15 Option Award |
2022-06-17 08:24 am |
N/A 2032-06-15 |
Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:27 pm |
N/A 2032-05-31 |
Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner |
8,293 | $0 | 8,293 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:31 pm |
N/A 2031-05-31 |
Keros Therapeutics Inc. | KROS | Kariv Tomer Director 10% Owner |
8,293 | $0 | 8,293 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:10 pm |
N/A 2031-05-19 |
Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:10 pm |
N/A 2030-05-20 |
Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director |
20,000 | $0 | 20,000 (Direct) |
View |